期刊文献+

Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan 被引量:1

Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan
下载PDF
导出
摘要 AIM: To measure patient perceptions about preventing hepatocellular carcinoma (HCC) and to predict the factors that influence patient willingness to receive therapy. METHODS: A cross-sectional descriptive study was conducted at an outpatient clinic of a medical institution in southern Taiwan. Four hundred patients with chronic hepatitis B/C were recruited as participants. Two structured questionnaires based on the health belief model were utilized in this study, including the scales of perceptions about preventing HCC and knowledge of hepatitis B/C. RESULTS: The statistical results demonstrated that the participants' perceived susceptibility (r = -0.22, P < 0.001), benefits (r = -0.11, P = 0.028) and cues to action (r = -0.12, P = 0.014) about the prevention ofHCC was significantly correlated with their age. The participants' perceptions were also associated with their educational levels, household incomes and knowledge of hepatitis. Older patients and those with a lower socioeconomic status tended to have negative perceptions and less knowledge of hepatitis. Multivariate logistic regression further indicated that the participants' age (B = -0.044, SE = 0.017, odds ratio = 0.957, P = 0.008, 95%CI: 0.926-0.989) and perceived barriers (B = -0.111, SE = 0.030, odds ratio = 0.895, P < 0.001, 95%CI: 0.845-0.949) were correlated with their willingness to receive antiviral therapy. CONCLUSION: Healthcare professionals should provide appropriate and effective guidance to increase their patients' awareness and to decrease the perceived barriers for continuing surveillance and antiviral therapy. AIM: To measure patient perceptions about preventing hepatocellular carcinoma (HCC) and to predict the factors that influence patient willingness to receive therapy. METHODS: A cross-sectional descriptive study was conducted at an outpatient clinic of a medical institution in southern Taiwan. Four hundred patients with chronic hepatitis B/C were recruited as participants. Two structured questionnaires based on the health belief model were utilized in this study, including the scales of perceptions about preventing HCC and knowledge of hepatitis B/C. RESULTS: The statistical results demonstrated that the participants’ perceived susceptibility (r = -0.22, P < 0.001), benefits (r = -0.11, P = 0.028) and cues to action (r = -0.12, P = 0.014) about the prevention of HCC was significantly correlated with their age. The participants’ perceptions were also associated with their educational levels, household incomes and knowledge of hepatitis. Older patients and those with a lower socioeconomic status tended to have negative perceptions and less knowledge of hepatitis. Multivariate logistic regression further indicated that the participants’ age (B = -0.044, SE = 0.017, odds ratio = 0.957, P = 0.008, 95%CI: 0.926-0.989) and perceived barriers (B = -0.111, SE = 0.030, odds ratio = 0.895, P < 0.001, 95%CI: 0.845-0.949) were correlated with their willingness to receive antiviral therapy. CONCLUSION: Healthcare professionals should provide appropriate and effective guidance to increase their patients’ awareness and to decrease the perceived barriers for continuing surveillance and antiviral therapy.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第22期3459-3465,共7页 世界胃肠病学杂志(英文版)
基金 Supported by E-Da Hospital,EDAHP99021
关键词 ANTIVIRAL therapy HEALTH perception HEPATITIS B HEPATITIS C HEPATOCELLULAR carcinoma HEALTH knowledge Antiviral therapy Health perception Hepatitis B Hepatitis C Hepatocellular carcinoma Health knowledge
  • 相关文献

参考文献13

  • 1Chun-Tao Wai,Belinda Mak,Winnie Chua,Mei-Hua Tan,Seline Ng,Amelia Cheok,Mee-Lian Wong,Seng-Gee Lira.Misperceptions among patients with chronic hepatitis B in Singapore[J].World Journal of Gastroenterology,2005,11(32):5002-5005. 被引量:2
  • 2Chiehwen Ed Hsu,Guangyu Zhang,Fang Alice Yan,Ning Shang,Tuan Le.What Made a Successful Hepatitis B Program for Reducing Liver Cancer Disparities: An Examination of Baseline Characteristics and Educational Intervention, Infection Status, and Missing Responses of At-Risk Asian Americans[J].Journal of Community Health.2010(3)
  • 3Grace X. Ma,Carolyn Y. Fang,Steven E. Shive,Jamil Toubbeh,Yin Tan,Philip Siu.Risk Perceptions and Barriers to Hepatitis B Screening and Vaccination among Vietnamese Immigrants[J].Journal of Immigrant and Minority Health.2007(3)
  • 4Robotin, M. C,George, J,Supramaniam, R,Sitas, F,Penman, A. G.Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy?[].Medical Journal of Australia.2008
  • 5Wilson,JF.Liver cancer on the rise[].Annals of Internal Medicine.2005
  • 6Wai CT,Wong ML,Cheok A, et al.Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B[].Alimentary Pharmacology and Therapeutics.2005
  • 7Champion,V. L.Instrument development for health belief model constructs[].Advances in Nursing Science.1984
  • 8GX Ma,SE Shive,JI Toubbeh,Y Tan,D Wu.Knowledge, attitudes, and behaviors of Chinese hepatitis B screening and vaccination[].American Journal of Health Behavior.2008
  • 9SS Yarbrough,CJ Braden.Utility of health belief model as a guide for explaining or predicting breast cancer screening behaviours[].Journal of Advanced Nursing.2001
  • 10G Hislop,C-Z Teh,A Low.Hepatitis B knowledge, testing and vaccination levels in Chinese immigrants to British Columbia, Canada[].Canadian Journal of Public Health.2007

二级参考文献15

  • 1Lok A, McMahon BJ. Chronic hepatitis B. Hepatology 200; 34:1225-1241.
  • 2de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A,McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J,Rosenberg W, Valla D. EASL Jury. EASL internationalconsensus conference on hepatitis B. 13-14 september, 2002 genera switzerland consensus statement (long rersion). J Hevatol 2003: 39:S3-25.
  • 3James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E,Chew SK. Hepatitis B seroprevalence study 1999. Singapore Med J 2001; 42:420-424.
  • 4Ministry Of Health, Singapore. Statistics: Health facts Singapore 2002. http://app.moh.gov.sg/sta/sta0202.asp#sta0202. Accessed March 2004.
  • 5Wai CT, Lok ASF. Treatment of hepatitis B. J Gastroenterol 2002; 37:771-778.
  • 6Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 1995; 10:683-690.
  • 7McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A,Sacco F, Dunaway E, Williams J. Screening for hepatocellular carcinoma in Alaska Natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32:842-846.
  • 8Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E.Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78:977-985.
  • 9Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y,Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-687.
  • 10Core working party for Asia-Pacific consensus on hepatitis B and C. Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region.Core Working Party for Asia-Pacific Consensus on Hepatitis B and C. J Gastroenterol Hepatol 2000; 15:825-841.

共引文献1

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部